F-Prime Capital Partners

F-Prime Capital Partners

Pulse 2.0

Checkmate Pharmaceuticals (CMPI) Stock: Why The Price Increased Over 320% Today

MedCity News

Apellis Pharma eyes a shot at getting first FDA approval in rare vision disorder

Pulse 2.0

Orchard Therapeutics Stock (ORTX): $9 Price Target From Cantor Fitzgerald

Pulse 2.0

Caribou Biosciences (CRBU) Stock: $28 Price Target From H.C. Wainwright

Pulse 2.0

Adagene (ADAG) Stock: Why The Price Increased Today


Hotel business intelligence platform OTA Insight nabs $80M

$100,000,000 Venture capital (Series B)
VentureBeat , SiliconANGLE

Notable aims to improve AI in health care with new $100M


Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics

$10,900,000 Venture capital (Series A)
Pulse 2.0

Robotics Company Burro Closes $10.9 Million


Former Iora Health execs raise $13M to guide seniors through Medicare enrollment

MedCity News

CRISPR biotech Caribou Biosciences’ IPO reels in $304M for next-gen cell therapy

$80,000,000 Venture capital (Series D)
WSJ Venture Capital

Cancer Drugmaker Turnstone Biologics Raises $80 Million


Protenus and UC Davis Health Present at HIMSS21 on Leveraging Artificial Intelligence to Reduce …

$21,000,000 Venture capital (Series D)
Technical.ly Baltimore

Baltimore healthcare analytics company Protenus raises $21M in Series D round

Pulse 2.0

One Medical (ONEM) Announces Deal To Buy Iora Health In $2.1 Billion Deal: Details


PE-backed Appriss Health acquires PatientPing

$22,500,000 Venture capital (Series C)

Dental platform CareStack gets funding from existing investors in extended round


Notable Health seeks to improve COVID-19 vaccine administration through intelligent automation

$34,000,000 Venture capital (Series B)
Pulse 2.0 , AlleyWatch

Digital Health Plan Company Centivo Raises $34 Million


Chinese biotech firm Adagene plans $200m US IPO